Live attenuated vaccine or inactivated vaccine

0 marketed 2 in Phase 3

This page covers all Live attenuated vaccine or inactivated vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Varicella-zoster virus (VZV) glycoproteins, Varicella-zoster virus (VZV) antigens.

Targets

Varicella-zoster virus (VZV) glycoproteins · Varicella-zoster virus (VZV) antigens

Phase 3 pipeline (2)

Chickenpox Vaccines · Southeast University, China · Immunology / Infectious Disease
This vaccine stimulates the immune system to produce antibodies and cellular immunity against varicella-zoster virus, preventing chickenpox infection.
Investigational varicella vaccine_Lot 1 · GlaxoSmithKline · Immunology / Infectious Disease
This investigational vaccine stimulates the immune system to recognize and prevent varicella-zoster virus infection by inducing protective antibodies and cell-mediated immunity.